Monte Rosa Therapeutics

Monte Rosa Therapeutics: Clinical Stage, next-generation molecular glue-based targeted protein degradation platform developing small molecule therapeutics that selectively degrade disease-causing proteins. AI-based degron prediction targets the undruggable proteome in both oncology and other disease areas. Extensive preclinical data demonstrating potent anti-tumor activity. Lead asset MRT-2359 targeting degradation of GSPT1 and dosed first patient in 4Q22 in a Phase 1/2 study in patients with MYC-driven solid tumors, including lung cancer.

Sector/Industry:

Healthcare/Biotechnology

Characteristics:

Based in...

Europe, US - New England

Clinical Stage

Phase l or ll, Pre-Clinical Stage

Disease Space

Oncology

Listing

Public, USA

Market Cap

100MM - 500MM

Therapeutic Modalities

Platform Technology, Protein Degradation

Website:

https://www.monterosatx.com/

Profiles:

Address:

WKL-136.3
Klybeckstrasse 191
Basel, Basel-Stadt
Switzerland

Presentation:

Please reach out to Solebury Strategic Communications to request a presentation

More info:

Send Message to Request Information

My account:

Company Participants at Solebury Trout 1x1 Management Access Event 2022

Markus Warmuth, CEO

Top 10 Holders of Monte Rosa Therapeutics, Inc.

Institution	OS (%)	Position	Mkt Val ($MM)	Source	Filing Date
NEA Management Co.	15.89	7,692,298	55.54	13F	12/31/22
Fidelity Management & Research Co. LLC	10.00	4,838,091	34.93	13F	12/31/22
Avoro Capital Advisor LLC	8.94	4,325,000	31.23	13F	12/31/22
T. Rowe Price Associates, Inc. (Investment Management)	7.61	3,683,430	26.59	13F	12/31/22
Cormorant Asset Management LP	5.98	2,893,717	20.89	13F	12/31/22
T. Rowe Price Investment Management, Inc.	4.00	1,934,539	13.97	13F	12/31/22
HBM Partners AG (Investment Management)	3.33	1,609,633	11.62	Funds	12/31/22
Aisling Capital Management LP	3.04	1,472,331	10.63	13F	12/31/22
Alphabet, Inc.	3.02	1,464,015	10.57	13F	12/31/22
The Vanguard Group, Inc.	2.89	1,399,354	10.10	Funds	2/28/23

Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...

Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.